Table 3 Average annual incidence by sex and 5-year age group, Australia, 1997–2006a,b
From: Trends in incidence of childhood cancer in Australia, 1983–2006
Diagnostic group | Males | Females | 0–4 years | 5–9 years | 10–14 years |
|---|---|---|---|---|---|
All childhood cancers | |||||
Average cases per year | 336.7 | 281.7 | 284.6 | 156.4 | 177.4 |
Rate per million | 167.2 | 147.2 | 222.9 | 117.2 | 130.8 |
95% CI | (161.6–173.0) | (141.8–152.8) | (214.8–231.2) | (111.4–123.1) | (124.8–137.0) |
I. Leukaemias | |||||
Average cases per year | 112.9 | 94.3 | 108.0 | 55.2 | 44.0 |
Rate per million | 56.4 | 49.6 | 84.6 | 41.4 | 32.4 |
95% CI | (53.1–59.8) | (46.5–52.9) | (79.6–89.8) | (38.0–44.9) | (29.5–35.6) |
II. Lymphomas | |||||
Average cases per year | 42.4 | 19.6 | 10.2 | 19.1 | 32.7 |
Rate per million | 20.6 | 10.0 | 8.0 | 14.3 | 24.1 |
95% CI | (18.7–22.6) | (8.6–11.4) | (6.5–9.7) | (12.4–16.5) | (21.6–26.9) |
III. CNS c | |||||
Average cases per year | 75.4 | 65.1 | 55.8 | 47.6 | 37.1 |
Rate per million | 37.3 | 33.9 | 43.7 | 35.7 | 27.4 |
95% CI | (34.7–40.0) | (31.4–36.6) | (40.2–47.5) | (32.5–39.0) | (24.6–30.3) |
IV. Neuroblastomas | |||||
Average cases per year | 18.7 | 17.9 | 32.0 | 3.5 | 1.1 |
Rate per million | 9.6 | 9.7 | 25.1 | 2.6 | 0.8 |
95% CI | (8.3–11.1) | (8.3–11.2) | (22.4–28.0) | (1.8–3.6) | (0.4–1.5) |
V. Retinoblastomas | |||||
Average cases per year | 8.9 | 5.9 | 14.0 | 0.8 | 0.0 |
Rate per million | 4.6 | 3.2 | 11.0 | 0.6 | — |
95% CI | (3.7–5.6) | (2.4–4.1) | (9.2–12.9) | (0.3–1.2) | — |
VI. Renal tumours | |||||
Average cases per year | 14.4 | 18.1 | 24.8 | 5.9 | 1.8 |
Rate per million | 7.3 | 9.7 | 19.4 | 4.4 | 1.3 |
95% CI | (6.2–8.6) | (8.3–11.2) | (17.1–22.0) | (3.4–5.7) | (0.8–2.1) |
VII. Hepatic tumours | |||||
Average cases per year | 6.2 | 3.6 | 7.7 | 1.0 | 1.1 |
Rate per million | 3.2 | 1.9 | 6.0 | 0.7 | 0.8 |
95% CI | (2.4–4.0) | (1.4–2.7) | (4.8–7.5) | (0.4–1.4) | (0.4–1.5) |
VIII. Malignant bone tumours | |||||
Average cases per year | 13.1 | 13.2 | 2.5 | 6.6 | 17.2 |
Rate per million | 6.3 | 6.7 | 2.0 | 4.9 | 12.7 |
95% CI | (5.3–7.5) | (5.6–7.9) | (1.3–2.9) | (3.8–6.3) | (10.9–14.7) |
IX. Soft tissue sarcomas | |||||
Average cases per year | 18.7 | 14.5 | 12.8 | 8.7 | 11.7 |
Rate per million | 9.3 | 7.5 | 10.0 | 6.5 | 8.6 |
95% CI | (8.0–10.7) | (6.3–8.8) | (8.4–11.9) | (5.2–8.0) | (7.1–10.3) |
X. Germ cell tumours c | |||||
Average cases per year | 12.4 | 12.7 | 13.8 | 3.2 | 8.1 |
Rate per million | 6.3 | 6.6 | 10.8 | 2.4 | 6.0 |
95% CI | (5.2–7.5) | (5.5–7.9) | (9.1–12.8) | (1.6–3.4) | 6.0 (4.7–7.4) |
XI. Malignant epithelial tumours and melanomas | |||||
Average cases per year | 12.6 | 16.4 | 2.3 | 4.8 | 21.9 |
Rate per million | 6.0 | 8.3 | 1.8 | 3.6 | 16.1 |
95% CI | (5.0–7.2) | (7.0–9.6) | (1.1–2.7) | (2.7–4.8) | (14.1–18.4) |
XII. Other and unspecified malignant neoplasms | |||||
Average cases per year | 1.0 | 0.4 | 0.7 | 0.0 | 0.7 |
Rate per million | 0.5 | 0.2 | 0.5 | — | 0.5 |
95% CI | (0.2–0.9) | (0.1–0.5) | (0.2–1.1) | — | (0.2–1.1) |
